Business Context and Reporting Period
Company: Ecovyst Inc.
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and six months ended June 30, 2026
Business Overview: Ecovyst is a leading provider of regenerated sulfuric acid, virgin sulfuric acid, and sulfur dioxide derivatives. The company supports the refining, mining, and industrial sectors. A significant event during the period was the acquisition of the Calabrian sulfur dioxide and sulfur derivatives business on June 30, 2026, expanding product offerings into sodium bisulfite, sodium thiosulfate, and sodium metabisulfite. The company also completed the divestiture of its Advanced Materials & Catalysts business in late 2025, which is reported as discontinued operations.
Key Financial Metrics
| Metric (in millions) | Q2 2026 | Q2 2025 | 6M 2026 | 6M 2025 |
|---|---|---|---|---|
| Sales | $249.96 | $176.07 | $464.91 | $319.18 |
| Gross Profit | $49.85 | $40.16 | $86.26 | $59.26 |
| Gross Margin | 19.9% | 22.8% | 18.6% | 18.6% |
| Operating Income | $19.36 | $15.78 | $31.90 | $14.80 |
| Net Income (Continuing Ops) | $10.70 | $5.02 | $16.44 | $(3.11) |
| Net Income (Total) | $7.87 | $5.99 | $12.18 | $2.39 |
| Diluted EPS (Total) | $0.07 | $0.05 | $0.11 | $0.02 |
| Operating Cash Flow (6M) | $55.18 (Continuing Ops) | |||
| Free Cash Flow (6M) | $10.38 (Continuing Ops, excluding CapEx) | |||
| Total Debt | $497.09 (as of June 30, 2026) | |||
| Cash & Equivalents | $87.76 (as of June 30, 2026) | |||
| Net Debt | $409.33 (as of June 30, 2026) |
Material Changes vs. Prior Period
- Revenue Growth: Sales increased 42.0% in Q2 2026 and 45.6% for the six months ended June 30, 2026, compared to the prior year. This was driven by higher average selling prices (pass-through of sulfur costs) and increased volume in regenerated and virgin sulfuric acid.
- Profitability: Operating income rose 22.8% in Q2 and 115.5% for the six-month period. Net income from continuing operations improved significantly, turning from a loss of $3.11 million in the first half of 2025 to a profit of $16.44 million in the first half of 2026.
- Acquisition Impact: The company acquired the Calabrian business for approximately $190 million (net cash paid $183.3 million) on June 30, 2026. This transaction added $71.5 million in goodwill and expanded the product portfolio. There were no net sales from Calabrian included in the period as the deal closed on the last day.
- Discontinued Operations: The company reported a net loss from discontinued operations of $2.83 million in Q2 and $4.26 million for the six months, primarily due to a $3.75 million post-closing purchase price adjustment related to the sale of the Advanced Materials & Catalysts business.
- Debt Structure: Total debt increased by $100 million in Q2 2026 due to an incremental term loan used to finance the Calabrian acquisition. Interest expense decreased year-over-year due to lower outstanding debt balances in the prior year periods.
Guidance, Outlook, and Risks
- Management Commentary: Management highlighted strong demand for refined products and favorable contractual pricing for regenerated sulfuric acid. The company expects to realize synergies from the Calabrian acquisition, though integration risks remain.
- Liquidity: As of June 30, 2026, the company had $87.8 million in cash and $88.5 million available under its Asset-Based Lending (ABL) facility, totaling $176.3 million in liquidity. Management believes this is sufficient for the next 12 months.
- Capital Allocation: The company continues its stock repurchase program, having repurchased 3.23 million shares in the first half of 2026 for $35.7 million. $146.5 million remains available under the program.
- Risks: Key risks include the successful integration of the Calabrian business, exposure to raw material price volatility (specifically sulfur and natural gas), seasonal demand fluctuations, and compliance with environmental regulations. The company also faces risks related to its substantial level of indebtedness.
- Unusual Items: "Other operating expense, net" increased significantly due to transaction costs ($9.4 million for 6M 2026) and a net loss on asset disposals ($2.6 million for 6M 2026). Debt modification costs of $1.0 million were incurred in both Q2 and the six-month period related to the term loan amendment.
Investor Verification Checklist
- Acquisition Integration: Verify the timeline and cost of integrating the Calabrian business and the realization of projected synergies.
- Discontinued Operations Adjustment: Confirm the finality of the $3.75 million post-closing purchase price adjustment related to the Advanced Materials & Catalysts divestiture.
- Debt Covenants: Review compliance with the fixed-charge coverage ratio and ABL facility availability thresholds following the increased debt load.
- Raw Material Pass-Through: Assess the sustainability of the sulfur cost pass-through mechanism in customer contracts and its impact on future gross margins.
- Seasonality: Monitor Q3 and Q4 sales trends to confirm the expected seasonal decline in regenerated sulfuric acid demand.